BLUEPRINT MEDICINES CORPORATION Increase (Decrease) in Accounts Payable and Accrued Liabilities
BLUEPRINT MEDICINES CORPORATION reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $3.45 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2024-10-30
- 2024-09-30: Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month $3.45M.
- 2023-09-30: Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month -$10.86M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month |
|---|---|
| 2024-09-30 | $3.45M 10-Q · filed 2024-10-30 |
| 2023-09-30 | -$10.86M 10-Q · filed 2024-10-30 |